EP2858640

Composition for use in a method of treating overweight and obesity in patients with high cardiovascular risk

  • :
    EP einkaleyfi: Þýðing ekki lögð inn
  • :
    5.6.2013
  • :
    25.3.2020
  • :
    13800883.4
  • :
    4.6.2033
  • :
    Composition for use in a method of treating overweight and obesity in patients with high cardiovascular risk

5.6.2013
25.3.2020
  • :
    Nalpropion Pharmaceuticals LLC
  • :
    10 North Place Park, Suite 201, Morristown, NJ 07960, US
  • :
    KLASSEN, Preston
  • :
    La Jolla, CA 92037, US
  • :
    TAYLOR, Kristin
  • :
    San Diego, CA 92127, US
  • :
    201261656451 P
  • :
    6.6.2012
  • :
    US
  • :
    US2013044368
  • :
    5.6.2013
  • :
    A61K 31/137, A61K 31/485, A61K 9/20, G01G 19/414, G09B 5/06, G09B 19/00, A61P 3/04, A61P 9/00, A61P 9/04, A61P 9/10